SA55 Injection
PRO-SA55-2001
Phase 2 small_molecule active
Quick answer
SA55 Injection for Infection of Upper Respiratory Tract Caused by 2019-nCoV is a Phase 2 program (small_molecule) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Infection of Upper Respiratory Tract Caused by 2019-nCoV
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active